Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2023

Open Access 01-12-2023 | Myasthenia Gravis | Research

Detection of Epstein–Barr virus infection in thymic epithelial tumors by nested PCR and Epstein–Barr-encoded RNA ISH

Authors: Li Zhao, Jian-Yong Ding, Yun-Lan Tao, Kun Zhu, Gang Chen

Published in: Infectious Agents and Cancer | Issue 1/2023

Login to get access

Abstract

Background

Epstein–Barr virus (EBV) is well known to be associated with a lot of tumors, including lymphoma, nasopharyngeal carcinoma, EBV-associated gastric carcinoma, and some other carcinomas with similar lymphoepithelioma-like features. However, the association between EBV and thymic epithelial tumors (TETs) is inconclusive as reports in this regard are not entirely consistent and the methods employed are of different sensitivity and specificity. The geographical difference of the patients is also one of the reasons for the different points of view.

Methods

In our study, we examined 72 thymomas, including 3 cases of type A thymomas, 27 cases of type AB, 6 cases of type B1, 26 cases of type B2 and 10 cases of type B3 thymomas, and 15 thymic carcinomas to detect the viral genome at both DNA and RNA levels. The genome DNA of fresh tissues was first screened by nested polymerase chain reaction (PCR), which could be regarded as the most sensitive method to detect small amounts of DNA. Then all the tissue blocks were further submitted for viral localization by Epstein–Barr-encoded RNA (EBER) ISH. Group parameters were assessed using the chi-square test at a significance level of p < 0.05.

Results

Nested PCR results showed that none of type A, eight (29.6%) type AB, one (16.7%) type B1, fifteen (57.7%) type B2, and four (40.0%) type B3 were positive for EBV genome. However, none of them detected EBER expression except for one case of type B2 thymoma. Fourteen (93.3%) thymic carcinomas were positive for EBV by nested PCR, of which three displayed weak nuclear signals within the tumor cells by EBER ISH.

Conclusions

These results showed that nested PCR was a sensitive method for screening the EBV genome in thymic epithelial tumors. As the malignancy of thymoma increases, the rate of EBV infection became higher. Thymic carcinomas were well associated with the Epstein–Barr virus.There was significant association between the EBV infection rate and thymoma type (p < 0.05). We further analyzed the association between EBV infection and myasthenia gravis. However, it showed no significant difference(p = 0.2754), although the EBV infection rate was higher in the thymomas with myasthenia gravis.
Literature
1.
go back to reference Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s Lymphoma. Lancet. 1964;1(7335):702–3.CrossRefPubMed Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s Lymphoma. Lancet. 1964;1(7335):702–3.CrossRefPubMed
2.
go back to reference Balfour HH, Sifakis J, Sliman F, Knight JA, Schmeling JA, Thomas DO. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208(8):1286–93.CrossRefPubMed Balfour HH, Sifakis J, Sliman F, Knight JA, Schmeling JA, Thomas DO. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208(8):1286–93.CrossRefPubMed
3.
go back to reference Neves M, Marinho-Dias J, Ribeiro J, Sousa H. Epstein-Barr virus strains and variations: Geographic or disease-specific variants? J Med Virol. 2017;89(3):373–87.CrossRefPubMed Neves M, Marinho-Dias J, Ribeiro J, Sousa H. Epstein-Barr virus strains and variations: Geographic or disease-specific variants? J Med Virol. 2017;89(3):373–87.CrossRefPubMed
4.
go back to reference Wang L, Song YL, Huang SM, Tao HX, Zhao YQ, Yan N, Xu DY. [The clinical significance of EBV DNA analysis in nasopharyngeal carcinoma screening]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(4):298–301. Wang L, Song YL, Huang SM, Tao HX, Zhao YQ, Yan N, Xu DY. [The clinical significance of EBV DNA analysis in nasopharyngeal carcinoma screening]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(4):298–301.
5.
go back to reference Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235(2):312–22.CrossRefPubMed Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235(2):312–22.CrossRefPubMed
6.
go back to reference Sasaki S, Nishikawa J, Sakai K, Iizasa H, Yoshiyama H, Yanagihara M, Shuto T, Shimokuri K, Kanda T, Suehiro Y, Yamasaki T, Sakaida I. EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions. Gastric Cancer. 2019;22(3):486–96.CrossRefPubMed Sasaki S, Nishikawa J, Sakai K, Iizasa H, Yoshiyama H, Yanagihara M, Shuto T, Shimokuri K, Kanda T, Suehiro Y, Yamasaki T, Sakaida I. EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions. Gastric Cancer. 2019;22(3):486–96.CrossRefPubMed
7.
go back to reference Mozaffari HR, Ramezani M, Janbakhsh A, Sadeghi M. Malignant salivary gland tumors and Epstein-Barr Virus (EBV) infection: a systematic review and Meta-analysis. Asian Pac J Cancer Prev. 2017;18(5):1201–6.PubMedPubMedCentral Mozaffari HR, Ramezani M, Janbakhsh A, Sadeghi M. Malignant salivary gland tumors and Epstein-Barr Virus (EBV) infection: a systematic review and Meta-analysis. Asian Pac J Cancer Prev. 2017;18(5):1201–6.PubMedPubMedCentral
8.
go back to reference Hong S, Liu D, Luo S, Fang W, Zhan J, Fu S, Zhang Y, Wu X, Zhou H, Chen X, Chen G, Zhang Z, Zheng Q, Li X, Chen J, Liu X, Lei M, Ye C, Wang J, Yang H, Xu X, Zhu S, Yang Y, Zhao Y, Zhou N, Zhao H, Huang Y, Zhang L, Wu K, Zhang L. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma. Nat Commun. 2019;10(1):3108.CrossRefPubMedPubMedCentral Hong S, Liu D, Luo S, Fang W, Zhan J, Fu S, Zhang Y, Wu X, Zhou H, Chen X, Chen G, Zhang Z, Zheng Q, Li X, Chen J, Liu X, Lei M, Ye C, Wang J, Yang H, Xu X, Zhu S, Yang Y, Zhao Y, Zhou N, Zhao H, Huang Y, Zhang L, Wu K, Zhang L. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma. Nat Commun. 2019;10(1):3108.CrossRefPubMedPubMedCentral
9.
go back to reference Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi M, Nonaka D, Papotti MG, Porubsky S, Sholl LM, Tateyama H, de Thomas V, Travis WD, Rajan A, Roden AC, Strobel P. The 2021 WHO classification of tumors of the Thymus and Mediastinum: what is New in Thymic Epithelial, Germ Cell, and mesenchymal tumors? J Thorac Oncol. 2022;17(2):200–13.CrossRefPubMed Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi M, Nonaka D, Papotti MG, Porubsky S, Sholl LM, Tateyama H, de Thomas V, Travis WD, Rajan A, Roden AC, Strobel P. The 2021 WHO classification of tumors of the Thymus and Mediastinum: what is New in Thymic Epithelial, Germ Cell, and mesenchymal tumors? J Thorac Oncol. 2022;17(2):200–13.CrossRefPubMed
10.
go back to reference McGuire LJ, Huang DP, Teoh R, Arnold M, Wong K, Lee JC. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol. 1988;131(3):385–90.PubMedPubMedCentral McGuire LJ, Huang DP, Teoh R, Arnold M, Wong K, Lee JC. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol. 1988;131(3):385–90.PubMedPubMedCentral
11.
go back to reference Chen PC, Pan CC, Yang AH, Wang LS, Chiang H. Detection of Epstein-Barr virus genome within thymic epithelial tumours in taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J Pathol. 2002;197(5):684–8.CrossRefPubMed Chen PC, Pan CC, Yang AH, Wang LS, Chiang H. Detection of Epstein-Barr virus genome within thymic epithelial tumours in taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J Pathol. 2002;197(5):684–8.CrossRefPubMed
12.
go back to reference Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, Strobel P. The 2015 World Health Organization classification of tumors of the Thymus: continuity and changes. J Thorac Oncol. 2015;10(10):1383–95.CrossRefPubMedPubMedCentral Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, Strobel P. The 2015 World Health Organization classification of tumors of the Thymus: continuity and changes. J Thorac Oncol. 2015;10(10):1383–95.CrossRefPubMedPubMedCentral
13.
go back to reference Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med. 1985;312(20):1296–9.CrossRefPubMed Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med. 1985;312(20):1296–9.CrossRefPubMed
14.
go back to reference Niehues T, Harms D, Jurgens H, Gobel U. Treatment of pediatric malignant thymoma: long-term remission in a 14-year-old boy with EBV-associated thymic carcinoma by aggressive, combined modality treatment. Med Pediatr Oncol. 1996;26(6):419–24.CrossRefPubMed Niehues T, Harms D, Jurgens H, Gobel U. Treatment of pediatric malignant thymoma: long-term remission in a 14-year-old boy with EBV-associated thymic carcinoma by aggressive, combined modality treatment. Med Pediatr Oncol. 1996;26(6):419–24.CrossRefPubMed
15.
go back to reference Stephan JL, Galambrun C, Boucheron S, Varlet F, Delabesse E, MacIntyre E. Epstein-Barr virus–positive undifferentiated thymic carcinoma in a 12-year-old white girl. J Pediatr Hematol Oncol. 2000;22(2):162–6.CrossRefPubMed Stephan JL, Galambrun C, Boucheron S, Varlet F, Delabesse E, MacIntyre E. Epstein-Barr virus–positive undifferentiated thymic carcinoma in a 12-year-old white girl. J Pediatr Hematol Oncol. 2000;22(2):162–6.CrossRefPubMed
16.
go back to reference Matsuno Y, Mukai K, Uhara H, Akao I, Furuya S, Sato Y, Hirohashi S, Shimosato Y. Detection of Epstein-Barr virus DNA in a japanese case of lymphoepithelioma-like thymic carcinoma. Jpn J Cancer Res. 1992;83(2):127–30.CrossRefPubMedPubMedCentral Matsuno Y, Mukai K, Uhara H, Akao I, Furuya S, Sato Y, Hirohashi S, Shimosato Y. Detection of Epstein-Barr virus DNA in a japanese case of lymphoepithelioma-like thymic carcinoma. Jpn J Cancer Res. 1992;83(2):127–30.CrossRefPubMedPubMedCentral
17.
go back to reference Giordano S, Pampinella D, Alu M, Agostara B, Romano A. [EBV reactivation in a patient undergoing chemotherapy for invasive thymoma]. Infez Med. 2007;15(3):195–8.PubMed Giordano S, Pampinella D, Alu M, Agostara B, Romano A. [EBV reactivation in a patient undergoing chemotherapy for invasive thymoma]. Infez Med. 2007;15(3):195–8.PubMed
18.
go back to reference Fujii T, Kawai T, Saito K, Fukushima K, Hasegawa T, Tokunaga M, Yokoyama T. EBER-1 expression in thymic carcinoma. Acta Pathol Jpn. 1993;43(3):107–10.PubMed Fujii T, Kawai T, Saito K, Fukushima K, Hasegawa T, Tokunaga M, Yokoyama T. EBER-1 expression in thymic carcinoma. Acta Pathol Jpn. 1993;43(3):107–10.PubMed
19.
go back to reference Takeuchi H, Fujita H, Iwasaki F, Takeuchi T, Imadome K, Okumiya T, Matsui T, Takahashi M. A case of Epstein-Barr Virus (EBV)-associated thymic carcinoid and investigation of existence of EBV-infected cells in thymus and thymic tumors. J Clin Microbiol. 2004;42(6):2850–4.CrossRefPubMedPubMedCentral Takeuchi H, Fujita H, Iwasaki F, Takeuchi T, Imadome K, Okumiya T, Matsui T, Takahashi M. A case of Epstein-Barr Virus (EBV)-associated thymic carcinoid and investigation of existence of EBV-infected cells in thymus and thymic tumors. J Clin Microbiol. 2004;42(6):2850–4.CrossRefPubMedPubMedCentral
20.
go back to reference Zhang G, Yu Z, Shen G, Chai Y, Liang C. Association between Epstein-Barr virus and thymic epithelial tumors: a systematic review. Infect Agent Cancer. 2019;14:32.CrossRefPubMedPubMedCentral Zhang G, Yu Z, Shen G, Chai Y, Liang C. Association between Epstein-Barr virus and thymic epithelial tumors: a systematic review. Infect Agent Cancer. 2019;14:32.CrossRefPubMedPubMedCentral
21.
go back to reference Engel PJ. Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA(EBER) in situ hybridization. APMIS. 2000;108(6):393–7.CrossRefPubMed Engel PJ. Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA(EBER) in situ hybridization. APMIS. 2000;108(6):393–7.CrossRefPubMed
22.
go back to reference Inghirami G, Chilosi M, Knowles DM. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. Am J Pathol. 1990;136(6):1429–36.PubMedPubMedCentral Inghirami G, Chilosi M, Knowles DM. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. Am J Pathol. 1990;136(6):1429–36.PubMedPubMedCentral
23.
go back to reference Csuka D, Banati M, Rozsa C, Fust G, Illes Z. High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis. Eur J Neurol. 2012;19(6):842–6.CrossRefPubMed Csuka D, Banati M, Rozsa C, Fust G, Illes Z. High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis. Eur J Neurol. 2012;19(6):842–6.CrossRefPubMed
24.
go back to reference Cavalcante P, Marcuzzo S, Franzi S, Galbardi B, Maggi L, Motta T, Ghislandi R, Buzzi A, Spinelli L, Novellino L, Baggi F, Antozzi C, Conforti F, De Pas TM, Barberis M, Bernasconi P, Mantegazza R. Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? Oncotarget 2017, 8, (56), 95432–95449. Cavalcante P, Marcuzzo S, Franzi S, Galbardi B, Maggi L, Motta T, Ghislandi R, Buzzi A, Spinelli L, Novellino L, Baggi F, Antozzi C, Conforti F, De Pas TM, Barberis M, Bernasconi P, Mantegazza R. Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? Oncotarget 2017, 8, (56), 95432–95449.
Metadata
Title
Detection of Epstein–Barr virus infection in thymic epithelial tumors by nested PCR and Epstein–Barr-encoded RNA ISH
Authors
Li Zhao
Jian-Yong Ding
Yun-Lan Tao
Kun Zhu
Gang Chen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2023
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/s13027-023-00497-9

Other articles of this Issue 1/2023

Infectious Agents and Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine